Recombinant human protein was used as the immunogen for the MYADM antibody.
MYADM (myeloid-associated differentiation marker) is an antigen in the cytoplasm of mature granulocytes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation. MYADM antibody reacts with early precursor and mature forms of human myeloid cells. It is useful for the detection of myeloid leukemias and granulocytic sarcomas.
Klonalität:
Monoclonal
Konzentration:
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Reinheit:
Protein G affinity chromatography
Formulierung:
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Target-Kategorie:
Myeloid Marker / MYADM
Antibody Type:
Primary Antibody
Application Verdünnung:
Immunohistochemistry (FFPE): 1-2ug/ml for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
Anwendungsbeschreibung:
Titering of the MYADM antibody may be required for optimal performance.1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
